Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Ferdinand KC, Selvaraj S, Alexander KM, Malhotra S

Open source

DOI
10.1007/s10741-026-10651-1
Published
2026 Jul 2
Container
Heart failure reviews
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10741-026-10651-1,
  title = {Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.},
  author = {Ferdinand KC and Selvaraj S and Alexander KM and Malhotra S},
  year = {2026},
  journal = {Heart failure reviews},
  doi = {10.1007/s10741-026-10651-1},
  url = {https://doi.org/10.1007/s10741-026-10651-1}
}

RIS

TY  - JOUR
TI  - Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.
AU  - Ferdinand KC
AU  - Selvaraj S
AU  - Alexander KM
AU  - Malhotra S
PY  - 2026
JO  - Heart failure reviews
DO  - 10.1007/s10741-026-10651-1
UR  - https://doi.org/10.1007/s10741-026-10651-1
ER  - 

APA

KC, F., S, S., KM, A., & S, M. (2026). Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.. Heart failure reviews. https://doi.org/10.1007/s10741-026-10651-1

Source records